Global and U.S. Veterinary Drugs Market
- 2026 年市場規模
- USD 24,905.8 Mn
- 2033 年預估規模
- USD 48,197.5 Mn
- 年複合成長率 CAGR
- 9.9%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
完整報告名稱與涵蓋範圍
Global and U.S. Veterinary Drugs Market, By Drug Type (Antibiotics, Nonsteroidal Anti-inflammatory Drug, Antiparasitic Drugs, Antihistamines, Antiemetic Drugs, Anti-ulcer Agents, Diuretics, Anaesthetic Agents, Anticancer Agents, Hormonal and Hormone Replacement Agents, Others), By Type (Branded, Generics), By Indication (Digestive System Disease, Immunologic Disease, Nervous System Disease, Reproductive System Disease, Respiratory System Disease, Dermatological Disease, Oncology, Hormonal Disorder, Cardiovascular Disease, Others), By Animal Type (Companion Animal, Livestock), By Route of Administration (Oral, Parenteral, Topical), By Dosage Form (Tablets and Capsules, Suspensions and Emulsions, Powders and Pastes, Gels, Creams and Ointments, Sprays, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies, Online Pharmacies, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
The global and U.S. veterinary drugs market is estimated to be valued at USD 24,905.8 Mn in 2026 and is expected to reach USD 48,197.5 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 9.9% from 2026 to 2033. The global and U.S. veterinary drugs market is a significant segment comprising pharmaceuticals such as antibiotics, antiparasitic, anti-inflammatories, and analgesics used to prevent and treat diseases in companion animals, livestock, and aquatic species. The demand for veterinary pharmaceuticals is being driven globally by the increasing pet humanization, growing demand for animal-derived protein, increasing prevalence of zoonotic diseases, and growing focus on animal welfare.
In the U.S., the safety, efficacy and quality of veterinary drugs is ensured by a robust regulatory system led by the U.S. FDA’s Center for Veterinary Medicine (FDA-CVM). On the global scale, growing livestock production, urbanization and heightened awareness of animal health are creating new opportunities for growth, while antimicrobial resistance is spurring innovation in drug development and responsible use.
Market Dynamics
The global and U.S. veterinary drugs market is driven by the rising pet population, increasing animal protein consumption, and rising demand for systematic livestock healthcare. Advancements in veterinary pharmaceuticals such as biologics, specialized therapies, and innovative drug-delivery systems, are creating extra treatment options, and the improvement of veterinary healthcare infrastructure in emerging economies is widening access to animal medicines.
However, the growth of organic capsules market is limited by factors such as stringent regulatory requirements, increasing concerns related to antimicrobial resistance and high veterinary treatment costs. Nevertheless, the growing trend toward preventive animal healthcare, development of digital veterinary services, increasing aquaculture health management and demand for antibiotic-free animal products are creating significant opportunities for innovative vaccines, long-acting therapies and precision-based veterinary treatments.
Key Features of the Study
• This report provides in-depth analysis of the global and U.S. veterinary drugs market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global and U.S. veterinary drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Zoetis Inc., Boehringer Ingelheim International GmbH, Merck & Co., Inc., Elanco Animal Health Incorporated, Virbac S.A., Ceva Santé Animale S.A., Dechra Pharmaceuticals Limited, Vetoquinol S.A., Phibro Animal Health Corporation, and Norbrook Laboratories Limited
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global and U.S. veterinary drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global and U.S. veterinary drugs market
Market Segmentation
• Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
o Antibiotics
o Nonsteroidal Anti-inflammatory Drug
o Antiparasitic Drugs
o Antihistamines
o Antiemetic Drugs
o Anti-ulcer Agents
o Diuretics
o Anaesthetic Agents
o Anticancer Agents
o Hormonal and Hormone Replacement Agents
o Others
• Type Insights (Revenue, USD Mn, 2021 - 2033)
o Branded
o Generics
• Indication Insights (Revenue, USD Mn, 2021 - 2033)
o Digestive System Disease
o Immunologic Disease
o Nervous System Disease
o Reproductive System Disease
o Respiratory System Disease
o Dermatological Disease
o Oncology
o Hormonal Disorder
o Cardiovascular Disease
o Others
• Animal Type Insights (Revenue, USD Mn, 2021 - 2033)
o Companion Animal
o Livestock
• Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
o Oral
o Parenteral
o Topical
• Dosage Form Insights (Revenue, USD Mn, 2021 - 2033)
o Tablets and Capsules
o Suspensions and Emulsions
o Powders and Pastes
o Gels, Creams and Ointments
o Sprays
o Others
• Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
o Veterinary Hospitals
o Veterinary Clinics
o Retail Pharmacies
o Online Pharmacies
o Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Zoetis Inc.
o Boehringer Ingelheim International GmbH
o Merck & Co., Inc.
o Elanco Animal Health Incorporated
o Virbac S.A.
o Ceva Sante Animale S.A.
o Dechra Pharmaceuticals Limited
o Vetoquinol S.A.
o Phibro Animal Health Corporation
o Norbrook Laboratories Limited
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global and U.S. Veterinary Drugs Market, By Drug Type
Global and U.S. Veterinary Drugs Market, By Type
Global and U.S. Veterinary Drugs Market, By Indication
Global and U.S. Veterinary Drugs Market, By Animal Type
Global and U.S. Veterinary Drugs Market, By Route of Administration
Global and U.S. Veterinary Drugs Market, By Dosage Form
Global and U.S. Veterinary Drugs Market, By Distribution Channel
Global and U.S. Veterinary Drugs Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Industry Trends
4. Global and U.S. Veterinary Drugs Market, By Drug Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Antibiotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Nonsteroidal Anti-inflammatory Drug
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Antiparasitic Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Antihistamines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Antiemetic Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Anti-ulcer Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Diuretics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Anaesthetic Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Anticancer Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Hormonal and Hormone Replacement Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global and U.S. Veterinary Drugs Market, By Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Branded
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Generics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global and U.S. Veterinary Drugs Market, By Indication, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Digestive System Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Immunologic Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Nervous System Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Reproductive System Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Respiratory System Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Dermatological Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Hormonal Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Cardiovascular Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global and U.S. Veterinary Drugs Market, By Animal Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Companion Animal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Livestock
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global and U.S. Veterinary Drugs Market, By Route of Administration, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Parenteral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global and U.S. Veterinary Drugs Market, By Dosage Form, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Tablets and Capsules
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Suspensions and Emulsions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Powders and Pastes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Gels, Creams and Ointments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Sprays
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global and U.S. Veterinary Drugs Market, By Distribution Channel, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Veterinary Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Veterinary Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
11. Global and U.S. Veterinary Drugs Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Animal Type,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
12. Competitive Landscape
o Zoetis Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Boehringer Ingelheim International GmbH
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Elanco Animal Health Incorporated
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Virbac S.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Ceva Sante Animale S.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Dechra Pharmaceuticals Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Vetoquinol S.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Phibro Animal Health Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Norbrook Laboratories Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
13. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
14. References and Research Methodology
o References
o Research Methodology
o About us
Browse 32 market data tables and 28 figures on ‘Veterinary Drugs Market' - Global and U.S. forecast to 2033
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們